In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
501 News Items found
Experimental Breast Cancer Drug Shows Promise in Aggressive Form of Disease

Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.
A section of breast tissue with cancerous changes identified.
In the Lab
A Deeper Vision: How Digital Technology Is Aiding Breast Cancer Diagnosis

By training computers to detect pathological changes in slides of tumor tissue, digital pathology promises to help doctors provide better patient care.
MSK investigators Michael Berger and David Solit.
Finding
Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.
Five people on the beach during a sunset
Ask the Expert
Does Vitamin D Reduce the Risk of Getting Cancer?

Two MSK medical oncologists discuss the link between the "sunshine vitamin" and cancer.
(Left to right) Sascha Roth, Luis Diaz, Imtiaz Hussain, Andrea Cercek, Avery Holmes, and Nisha Varughese.
Feature
Top Cancer Treatment Advances at MSK in 2022

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Here are some of the most important developments.
Beatriz Galvan treasures spending time with her granddaughter, Mia Camila, after being successfully treated for breast cancer at MSK.
How MSK Is Improving Cancer Treatment for Hispanic Patients

Learn how MSK helps people facing cancer in every way they need, and understands the importance of speaking to patients in the language that provides them peace of mind.
Increased Breast Cancer Risk Seen in Postmenopausal Women with High Body-Fat Levels Despite Normal BMI

MSK's Neil Iyengar will present at the American Association for Cancer Research special conference about the risk of invasive breast cancer. A new study found that the risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat. These findings suggest that having a normal BMI can provide false reassurance regarding the risk of breast cancer associated with body fat, and they also highlight the potential role of physical activity and exercise even in those who are at a normal weight. For expert interviews, please contact Nicole H. McNamara at [email protected].
MSK breast cancer patient Marcia McFayden seen smiling outdoors.
Living Better During Cancer and Beyond: The MSK Healthy Living Program

Learn about the MSK Healthy Living program that provides breast cancer patients with a custom plan tailored to their needs to help with nutrition and exercise, integrative medicine; support for mental, emotional, and spiritual well-being and much more.
Doctor and patient
In the Clinic
Study Asks: Are Women Missing Out on BRCA Testing?

Results from a study of women with breast and ovarian cancer show surprisingly low rates of genetic testing.
Laura Ostrowsky sitting at desk
Feature
From Employee to Patient: I Worked at MSK and Then Was Diagnosed with Breast Cancer

Find out what it’s like to undergo cancer treatment when you work at a cancer hospital like Memorial Sloan Kettering.